Expedited Review Mechanisms for Rare Disease Clinical Trials in Asia-Pacific
Expedited Review Mechanisms for Rare Disease Clinical Trials in Asia-Pacific Accelerating Rare Disease Clinical Trials: Asia-Pacific Expedited Review Pathways Introduction: The Growing Importance of Asia-Pacific in Rare Disease Trials As global pharmaceutical companies expand clinical research into emerging markets, the Asia-Pacific (APAC) region has gained increasing relevance in rare disease trials. Several countries in APAC—including…
Read More “Expedited Review Mechanisms for Rare Disease Clinical Trials in Asia-Pacific” »